Submit an Original Article

Can JAK Inhibitors Challenge Biologics?: Johnson & Johnson (JNJ) and More

From Insider Monkey - Free Hedge Fund and Insider Trading Data
February 20, 2013 - 2:37pm
When the word “biotechnology” gets thrown around in the pharmaceutical industry, it often implies the biomanufacturing of biologic drugs, such as therapeutic proteins. It makes sense to use these complex molecules from the body’s own defense mechanism — the immune system — to aid in suppressing and regulating various cellular pathways active during disease response. [...]

Continue reading this article »

Share This Article:

Submit an Original Article

Wall Street Buzz

MOST POPULAR